Hyperlipidemia and apolipoprotein E are associated with intraocular pressure of thyroid-associated ophthalmopathy in a Chinese population: a cross-sectional study.
Chen Y, Qi X, Wang J, Xu H, Sun Y, Wang L, Zhou X, He M, Zhao J, Zhang J, He H, Guo H, Shi B, Wang Y, Zhang M.
Front Endocrinol (Lausanne). 2024 Nov 28;15:1484343. doi: 10.3389/fendo.2024.1484343. eCollection 2024.
Obesity and dyslipidemia.
Howard BV, Ruotolo G, Robbins DC.
Endocrinol Metab Clin North Am. 2003 Dec;32(4):855-67. doi: 10.1016/s0889-8529(03)00073-2.
Effectiveness and safety of eleven Chinese patent medicines combined with atorvastatin in the treatment of hyperlipidemia: a network meta-analysis of randomized controlled trials.
Shi Z, Zheng W, Bu Z, Zhou X, Wang X, Song Y, Sun J, Liu JP, Liu ZL.
Front Endocrinol (Lausanne). 2025 Mar 24;16:1523553. doi: 10.3389/fendo.2025.1523553. eCollection 2025.
A novel mutation in C5L2 gene was associated with hyperlipidemia and retinitis pigmentosa in a Chinese family.
Qu LH, Jin X, Li LM, Li SY, Xie HP.
Lipids Health Dis. 2014 May 6;13:75. doi: 10.1186/1476-511X-13-75.
Cocoa and cardiovascular health.
Corti R, Flammer AJ, Hollenberg NK, Lüscher TF.
Circulation. 2009 Mar 17;119(10):1433-41. doi: 10.1161/CIRCULATIONAHA.108.827022.
Uric acid and left ventricular hypertrophy.
Saitoh S.
Circ J. 2009 Apr;73(4):624-5. doi: 10.1253/circj.cj-09-0092.
Obesity modulates NK cell activity via LDL and DUSP1 signaling for populations with adverse social determinants.
Baumer Y, Singh K, Saurabh A, Baez AS, Gutierrez-Huerta CA, Chen L, Igboko M, Turner BS, Yeboah JA, Reger RN, Ortiz-Whittingham LR, Joshi S, Andrews MR, Aquino Peterson EM, Bleck CK, Mendelsohn LG, Mitchell VM, Collins BS, Redekar NR, Kuhn SA, Combs CA, Pirooznia M, Dagur PK, Allan DS, Schwartz DM, Childs RW, Powell-Wiley TM.
JCI Insight. 2024 Dec 24;10(2):e180606. doi: 10.1172/jci.insight.180606.
Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW.
J Lipid Res. 1996 Jan;37(1):136-47.
[Hyperlipemia].
Goto Y.
Nihon Ishikai Zasshi. 1969 Jun 15;61(12):1381-6.
Tamoxifen Treatment and the Reduced Risk of Hyperlipidemia in Asian Patients With Breast Cancer: A Population-Based Cohort Study.
Lim YP, Lin CL, Lin YN, Ma WC, Hung DZ, Kao CH.
Clin Breast Cancer. 2015 Aug;15(4):294-300. doi: 10.1016/j.clbc.2015.03.005. Epub 2015 Mar 24.
